中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Immune Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
Upcoming Events
Corporate presentation
SCIENTIFIC PRESENTATIONS
News
Careers
Investors
Financials & Filing
Upcoming Events
Corporate presentation
SCIENTIFIC PRESENTATIONS
2026
2025
2024
2023
2022
2021
2020
2019
2018
2026
2025
2024
2023
2022
2021
2020
2019
2018
Notification Letter with Request Form to Non-Registered Holders of Shares - Notice of Publication of Interim Report 2018
2018-09-20
2018 Interim Report
2018-09-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2018
2018-09-06
2018 Interim Results
2018-08-31
Change of Principal Place of Business in Hong Kong
2018-08-31
STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF OVER-ALLOTMENT OPTION
2018-08-24
NOTICE OF BOARD MEETING
2018-08-20
VOLUNTARY ANNOUNCEMENT
2018-08-02
ANNOUNCEMENT - INSIDE INFORMATION - NEW DRUG APPLICATION FOR ALL-ORAL HCV TREATMENT FILED WITH CHINA FOOD AND DRUG ADMINISTRATION
2018-07-31
BOARD DIVERSITY POLICY
2018-07-31
«
1
2
3
4
»
浙公网安备 33010802003344号
浙ICP备11050387号-1